XML 26 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended 12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Dec. 31, 2019
Cash Flows From Operating Activities        
Net loss $ (10,401,863) $ (8,988,402) $ (17,036,837) $ (11,812,797)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation and amortization 1,678,067 503,384 687,845 478,191
Bad debt expense 79,305 12,000 12,000 23,500
Gain on forgiveness of debt (24,925) 0 (376,177) 0
Equity based compensation expense 3,543,887 2,646,013 3,212,772 4,643,127
Recognized loss on marketable securities 1,424 20,259 22,416 160,449
Gain on sale of asset     0 (27,000)
Marketable securities distributed as compensation     3,917 0
Expenses paid through financings 0 32,500 32,500 15,000
Loan principal paid directly through grant (2,992) (8,853) (8,853) 0
Amortization of debt discount and debt costs 2,503,160 1,029,882 1,840,745 39,372
Warrant modification expense 12,624 0    
Initial derivative expense 3,585,983 3,340,554 3,340,554 0
Change in derivative value due to anti-dilution adjustments 0 2,642,175 2,642,175 0
Change in fair value of derivative liability (7,315,580) (3,306,350) 2,658,261 (1,138,604)
Impairment expense 2,530,325 0 0 3,113,020
Change in fair value of earn-out liability 102,116 0    
Changes in assets and liabilities:        
(Increase) decrease in accounts receivable (3,517,385) 126,492 (94,767) (58,804)
Decrease in accounts receivable - related parties 15,043   (36,784) (4,340)
(Increase) decrease in prepaid expenses and other current assets (53,823) 25,950 (68,542) (73,620)
Increase (decrease) in accounts payable and accrued liabilities 642,427 (68,633) 626,895 2,752,033
Decrease in accounts payable and accrued liabilities - related parties (687,460) 0 (63,863) 507,425
Decrease in deferred payroll taxes (135,699) 0    
Increase in other liabilities (2,840) 132,950 173,525 0
(Decrease) increase in deferred revenue 456,824 (66,497) (93,937) 22,906
Net cash used in operating activities (6,985,702) (1,926,576) (2,526,155) (1,390,858)
Cash Flows From Investing Activities:        
Proceeds from sale of marketable securities 0 17,009 17,009 68,702
Cash paid for customer contacts 0 (50,000) (50,000) 0
Cash and receivables acquired 230,855 0    
Proceeds from sale of asset     0 27,000
Cash paid for equipment     0 (3,463)
Cash paid for software development     0 (11,500)
Cash paid for acquisitions (2,304,528) 0    
Net cash used in investing activities (2,073,673) (32,991) (32,991) 80,739
Cash Flows From Financing Activities:        
Proceeds from loans 250,000 398,545 398,545 45,005
Proceeds from convertible notes 2,153,200 2,226,000 2,476,000 0
Deferred offering costs (78,038)      
Repayments of notes (156,131) (11,155) (17,907) (105,034)
Advances on receivables 0 180,778 180,778 0
Repayments of advances on receivables 0 (180,778) (180,778) 0
Repayments of sale of future revenues (10,904) (403,617) (528,838) (27,259)
Proceeds from sale of future revenues     0 424,510
Deposit on purchase of preferred stock     0 500,000
Proceeds from sale of common stock 13,800,000 0    
Repayment of deposit on purchase of preferred stock     0 (215,000)
Offering costs (1,651,889)      
Proceeds from sale of preferred stock 0 25,000 25,000 979,997
Net cash provided by financing activities 14,306,238 2,234,773 2,352,800 1,602,219
Net increase in cash 5,246,863 275,206 (206,346) 292,100
Cash, beginning of period 99,906 306,252 306,252 14,152
Cash, end of period 5,346,769 581,458 99,906 306,252
Supplemental disclosures of cash flow information:        
Cash paid during the period for interest 175,580 128,979 235,813 49,552
Cash paid during the period for income taxes 0 0 0 0
Supplemental schedule of non-cash investing and financing activities:        
Original issue discount deducted from convertible note proceeds 342,554 328,125 328,125 0
Debt costs deducted from convertible note proceeds 334,800 366,500 366,500 0
Preferred stock issued for accrued penalties 0 1,929,516 1,929,516 0
Loans issued as consideration for acquisitions 4,750,000      
Notes and accrued interest converted to common stock 4,647,794 0 96,000 0
Preferred stock issued for asset acquisition     0 8,600,000
Non-cash adjustments to Redeemable Preferred Stock of subsidiary     0 2,059,764
Notes payable and accrued interest exchanged for preferred stock     0 116,380
Noncontrolling interest reclassified to paid-in capital     0 1,591,221
Accounts payable paid through proceeds of preferred stock     0 100,000
Common stock issued/to be issued for asset acquisitions 8,241,082 0    
Notes payable and accrued interest exchanged for debentures 252,430 0    
Accounts payable paid with common stock 140,000 0    
Accrued compensation paid with common stock 16,425 0 0 56,250
Value of warrant issued with note     0 42,000
Accounts payable paid through proceeds of note     0 4,995
Warrant derivative liability extinguished 10,182,476 0    
Write off of right-of-use asset and lease liability 103,953 0    
Earn-out liability consideration for acquisition 1,668,297 0    
Shares issued for upsider earn-out liability 1,394,768 0    
Deferred offering costs charged to additional paid-in capital 78,038 0    
Warrant derivative liability at inception 2,374,076 2,284,965 5,625,519 1,750,646
Accrued compensation forgiven and credited to contributed capital     0 187,500
Discount attributable to liability on sale future revenues     0 142,491
Discount attributable to note payable     0 10,000
Marketable securities received as payment for Series D preferred stock $ 0 $ 0 0 240,000
Notes and accrued interest forgiven     $ 0 $ 706,501